2,3-bis(4-hydroxyphenyl)-propionitrile and Hodgkin Disease

2,3-bis(4-hydroxyphenyl)-propionitrile has been researched along with Hodgkin Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ascione, B; Careddu, G; Carlo-Stella, C; Ciarlo, L; Locatelli, SL; Malorni, W; Maselli, A; Matarrese, P; Ortona, E; Patrizio, M; Pierdominici, M; Tinari, A	1

Other Studies

1 other study(ies) available for 2,3-bis(4-hydroxyphenyl)-propionitrile and Hodgkin Disease

Article	Year
Estrogen receptor β ligation inhibits Hodgkin lymphoma growth by inducing autophagy. Oncotarget, 2017, Jan-31, Volume: 8, Issue:5 Topics: Animals; Autophagy; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Estrogen Receptor beta; Gene Expression Regulation, Neoplastic; Hodgkin Disease; Humans; Ligands; Membrane Proteins; Mice, Inbred NOD; Mice, SCID; Microtubule-Associated Proteins; Nitriles; Selective Estrogen Receptor Modulators; Signal Transduction; Time Factors; Transfection; Xenograft Model Antitumor Assays	2017

Article

Year

Estrogen receptor β ligation inhibits Hodgkin lymphoma growth by inducing autophagy.

Oncotarget, 2017, Jan-31, Volume: 8, Issue:5

Topics: Animals; Autophagy; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Estrogen Receptor beta; Gene Expression Regulation, Neoplastic; Hodgkin Disease; Humans; Ligands; Membrane Proteins; Mice, Inbred NOD; Mice, SCID; Microtubule-Associated Proteins; Nitriles; Selective Estrogen Receptor Modulators; Signal Transduction; Time Factors; Transfection; Xenograft Model Antitumor Assays

2017